The use of Alimentary Tract and Metabolism Medicines in Australia has shown a fluctuating trend over the years. From 2013 to 2018, the usage hovered around 150 Units Per Thousand Persons Per Day, with minor variations. Post-2018, the trend has exhibited a consistent downward trajectory, with a notable decrease from 2019 onwards. Specifically, in 2023, the value stood at 137.8 Units Per Thousand Persons Per Day.
Recent year-on-year variations indicated: • 2022: -2.52% • 2023: -1.22%
The Compound Annual Growth Rate (CAGR) over the last five years is -1.79%, highlighting a steady decline. Forecasts predict further decreasing usage, with a projected five-year CAGR of -0.9% leading up to 2028.
Future trends to watch for include advancements in medical treatments and patient awareness possibly impacting demand, changes in healthcare policies, and emerging insights regarding the long-term effects and benefits of these medications.
